Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua

While therapeutic mesenchymal stromal/stem cells (MSCs) have usually been obtained from bone marrow, perinatal tissues have emerged as promising new sources of cells for stromal cell therapy.

Saved in:
Bibliographic Details
Main Authors: Moll, Guido (Author) , Jungebluth, Philipp (Author)
Format: Article (Journal)
Language:English
Published: 20 Jul 2015
In: Stem Cells and Development
Year: 2015, Volume: 24, Issue: 19, Pages: 2269-2279
ISSN:1557-8534
DOI:10.1089/scd.2015.0120
Online Access:Verlag, Volltext: https://doi.org/10.1089/scd.2015.0120
Verlag, Volltext: https://www.liebertpub.com/doi/abs/10.1089/scd.2015.0120
Get full text
Author Notes:Guido Moll, Lech Ignatowicz, Rusan Catar, Christian Luecht, Behnam Sadeghi, Osama Hamad, Philipp Jungebluth, Duska Dragun, Artur Schmidtchen, and Olle Ringdén
Description
Summary:While therapeutic mesenchymal stromal/stem cells (MSCs) have usually been obtained from bone marrow, perinatal tissues have emerged as promising new sources of cells for stromal cell therapy.
Item Description:Gesehen am 12.06.2020
Physical Description:Online Resource
ISSN:1557-8534
DOI:10.1089/scd.2015.0120